drugset / Trial / NCT07185841
Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of Oral HX9428 tablets in patients with wet age-related macular degeneration(wAMD)
Timeline
- Start
- 2025-07-01
- Primary completion
- 2028-07-01
- Completion
- 2029-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HX9428 | Unknown | 5 mg | Oral |